Clinical Trials Browser

Phase 1/2 × Adenocarcinoma Of Esophagus × Lymphoid × Clear all

NCT03789617 2022-07-11

A Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive Malignancies

Phase 1/2 Unknown

GastrointestinalLymphoid

Adenocarcinoma Of Esophagus, Lymphoma, Stomach Neoplasms